Medicines
Medicines
The content on this page is intended for members of the public.
We market medicines that are designed to improve the health and quality of life of patients in the UK.
If you would like to know about AstraZeneca’s list of Medicines in Great Britain and Northern Ireland, please select from the options below.
Report an adverse event
Report an adverse event
All pharmacologically effective drugs have benefits and risks. The risk may be insignificant or may be acceptable in relation to the drug’s therapeutic action. Continuous monitoring of the safety of a drug throughout the duration of its use helps to ensure that its risks and benefits remain acceptable.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to AstraZeneca on 0800 783 0033 and via contactazmedical@astrazeneca.com.
Reporting of side effects
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
Medical Information contact details
Medical Information contact details
Please contact our UK based Medical Information team
Call: 0800 783 0033.
Lines are open from Monday-Friday, 9am - 5pm.
If you are a patient who is currently taking an AstraZeneca medicine or device, further information, including device technique and patient education materials, may be accessed via our dedicated patient Medical Information website at www.myazmed.co.uk.
Supply Chain contact details
Supply Chain contact details
Our modern and simplified supply and delivery service ensures that all community pharmacies, dispensing doctors, and hospitals will have the right medicine, delivered to the right place, for every patient, at the right time.
For Healthcare Professionals who are interested in the status of our medicines please visit https://www.supplychain-astrazeneca.co.uk.

GB-57511 | DOP: July 2024